Results 231 to 240 of about 134,203 (255)
Some of the next articles are maybe not open access.
[Using thalidomide against pathological neovascularization].
Harefuah, 2003Thalidomide was first used during the 50's-60's, especially for morning sickness in pregnant women. It was found to be a powerful teratogen only years later and was banned from use. At the same time it was found to have anti-inflammatory and anti-angiogenic properties and was approved as treatment for leprosy. As such, thalidomide might be used against
Arik, Eisenkraft +3 more
openaire +1 more source
Nippon Ganka Gakkai zasshi, 1993
We describe early features of choroidal neovascularization in 50 pathologically myopic eyes. The eyes were classified into three categories on the basis of degree of myopic chorioretinal degeneration in the posterior pole: mild diffuse atrophy, severe diffuse atrophy and focal atrophy.
Y, Miyabe, M, Takeda
openaire +1 more source
We describe early features of choroidal neovascularization in 50 pathologically myopic eyes. The eyes were classified into three categories on the basis of degree of myopic chorioretinal degeneration in the posterior pole: mild diffuse atrophy, severe diffuse atrophy and focal atrophy.
Y, Miyabe, M, Takeda
openaire +1 more source
Conbercept for treatment of choroidal neovascularization secondary to pathologic myopia
Acta Ophthalmologica, 2018Ming Yan +4 more
openaire +2 more sources
Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization
Proceedings of the National Academy of Sciences of the United States of America, 2015Yan Gong, Ye Sun, Chi-Hsiu Liu
exaly
TREATMENT OF CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA WITH INTRAVITREAL BEVACIZUMAB
Retina, 2006Ketan, Laud +4 more
openaire +2 more sources
INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA
Retina, 2006Asheesh, Tewari +2 more
openaire +2 more sources